HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$26.53
Day range
$25.44 - $27.78
Year range
$14.42 - $38.93
Market cap
706.20M USD
Avg Volume
198.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.22M | -39.07% |
Net income | -12.65M | 46.60% |
Net profit margin | — | — |
Earnings per share | -0.46 | — |
EBITDA | -15.20M | 39.16% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 209.03M | 217.70% |
Total assets | 215.30M | 205.93% |
Total liabilities | 11.22M | -40.40% |
Total equity | 204.08M | — |
Shares outstanding | 27.54M | — |
Price to book | 3.58 | — |
Return on assets | -17.33% | — |
Return on capital | -18.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.65M | 46.60% |
Cash from operations | -9.08M | 56.71% |
Cash from investing | -11.86M | -178.18% |
Cash from financing | 53.00K | 102.77% |
Net change in cash | -20.89M | -170.99% |
Free cash flow | -4.55M | 65.45% |
About
Founded
2013
Headquarters
Website
Employees
42
